GSE230865 EYA2 knockdown 3 v 2 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE230865_EYA2 knockdown_3_v_2_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE230865_EYA2 knockdown_3_v_2_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE230865_EYA2 knockdown_3_v_2_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE230865_EYA2 knockdown_3_v_2_human_up.

Results found

Linked to

 

Label

Description

 

Gene

ral guanine nucleotide dissociation stimulator like 2

Gene

PAX8 antisense RNA 1

Gene

long intergenic non-protein coding RNA 665

Gene

ZNFX1 antisense RNA 1

Gene

dehydrogenase/reductase X-linked

Gene

p53 upregulated regulator of p53 levels

Gene

protein kinase Y-linked (pseudogene)

Gene

DPPA2 upstream binding RNA

Gene

MIR34A host gene

Gene

firre intergenic repeating RNA element

  • Gene

    ral guanine nucleotide dissociation stimulator like 2


  • Gene

    PAX8 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 665


  • Gene

    ZNFX1 antisense RNA 1


  • Gene

    dehydrogenase/reductase X-linked


  • Gene

    p53 upregulated regulator of p53 levels


  • Gene

    protein kinase Y-linked (pseudogene)


  • Gene

    DPPA2 upstream binding RNA



  • Gene

    firre intergenic repeating RNA element

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.